[ad_1]
MANILA – Clover Biopharmaceuticals is seeking late-stage clinical trials in the Philippines of its coronavirus vaccine, the head of the country’s food and drug agency said on Friday.
Clover is the second Chinese developer to apply for Phase 3 clinical trials in the Philippines after Sinovac Biotech, which is looking to begin trials of its vaccine next month.
The Director of the Food and Drug Administration (FDA), Rolando Enrique Domingo, told reporters that Clover’s COVID-19 vaccine would first be evaluated by a panel of experts before it could move on to the next stage of the approval process. .
The Philippines is also evaluating COVID-19 vaccines from Johnson & Johnson’s Janssen and Russia’s Gamaleya Research Institute for late-stage trials.
Philippine President Rodrigo Duterte has said that he prefers his country to obtain its COVID-19 vaccines from China or Russia.
He also said he wanted the entire population to be vaccinated, prioritizing the poor and the country’s security forces.
The Philippines has recorded 376,935 coronavirus cases and 7,147 deaths from COVID-19 as of Thursday, the second highest in Southeast Asia.
For more news on the new coronavirus, click here.
What you need to know about the coronavirus.
For more information on COVID-19, call the DOH hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our healthcare leaders and still accepts cash donations to be deposited into the Banco de Oro (BDO) checking account # 007960018860 or donate through PayMaya using this link .
Read next
Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer and more than 70 other titles, share up to 5 gadgets, listen to the news, download from 4am and share articles on social media. Call 896 6000.
For comments, complaints or inquiries, please contact us.
[ad_2]
